Related Experiment Video
Updated: Nov 24, 2025

Translational Rabbit Model of Chronic Cardiac Pacing
Published on: January 6, 2023
Lead performance and clinical outcomes of patients with permanent His-Purkinje system pacing: a single-centre
Zhiyong Qian1, Yuanhao Qiu1, Yao Wang1
1Department of Cardiology, The First Affiliated Hospital, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.
Insights
His-Purkinje system pacing, including His bundle (HB) and left bundle branch (LBB) pacing, offers benefits for heart failure patients. LBB pacing demonstrates superior lead parameters compared to HB pacing, though lead stability requires monitoring.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Pacing
Background:
- His-Purkinje system (HPS) pacing, encompassing His bundle (HB) and left bundle branch (LBB) pacing, is gaining prominence.
- Limited data exists comparing lead performance and clinical outcomes between HB and LBB pacing.
Purpose of the Study:
- To evaluate the mid-to-long-term lead performance and clinical outcomes of permanent HPS pacing.
- To compare HB pacing versus LBB pacing in a single center.
Main Methods:
- Retrospective analysis of 64 patients with HB pacing and 185 with LBB pacing.
- Assessment of pacing parameters, 12-lead ECG, echocardiography, and clinical outcomes during follow-up.
Main Results:
- LBB pacing showed a slightly longer paced QRS duration (117.7 ms vs. 113.7 ms).
- Immediate post-operation, LBB pacing had significantly higher R-wave amplitude and lower capture thresholds.
- During follow-up, LBB pacing demonstrated better lead stability with no increase in capture threshold, unlike HB pacing.
Conclusions:
- HPS pacing improves electrical synchrony and cardiac function in heart failure patients.
- LBB pacing exhibits superior pacing parameters compared to HB pacing.
- Lead micro-displacement and QRS morphology changes are potential concerns with LBB pacing.
Aims:
His-Purkinje system (HPS) pacing, including His bundle (HB) and left bundle branch (LBB) pacing, has emerged as a highlighted topic in recent years. Comparisons in lead performance and clinical outcomes between HB and LBB pacing were seldom reported. We aimed to investigate the mid-long-term lead performance and clinical outcomes of permanent HPS pacing patients in our centre.
Methods And Results:
Permanent HB pacing was implemented by placing the pacing lead helix at the HB area. Left bundle branch pacing was achieved by placing the lead helix in the left-side sub-endocardium of the interventricular septum. Pacing parameters, 12-lead ECG, echocardiography, and clinical outcomes were evaluated during follow-up. A total of 64 patients with HB pacing and 185 with LBB pacing were included. Left bundle branch pacing exhibited a slightly longer paced QRS duration than HB pacing (117.7 ± 11.0 vs. 113.7 ± 19.8 ms, P = 0.04). Immediate post-operation, LBB pacing had a significant higher R-wave amplitude (16.5 ± 7.5 vs. 4.3 ± 3.6 mV, P < 0.001) and lower capture threshold (0.5 ± 0.1 vs. 1.2 ± 0.8 V, P < 0.001) compared with HB pacing. During follow-up, an increase in capture threshold of >1.0 V from baseline was found in eight (12.5%) patients in the HB pacing group and none in LBB pacing. Paced QRS morphology changed from Qr to QS in lead V1 in seven patients (3.8%) with LBB pacing. Both HB and LBB pacing preserved cardiac function in patients with left ventricular ejection fraction (LVEF) over 50%. In patients with LVEF <50%, both HB and LBB pacing improved clinical outcomes during follow-up.
Conclusion:
His-Purkinje system pacing produced favourable electrical synchrony and improved cardiac function in patients with heart failure. Left bundle branch pacing showed superior pacing parameters over HB pacing. Lead micro-displacement with changes in paced QRS morphology posts a concern in LBB pacing.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10:05Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016